From: Risk-stratification in febrile infants 29 to 60 days old: a cost-effectiveness analysis
Preferred Strategy | ||||
---|---|---|---|---|
Variable | Base-case | Threshold | Below threshold | Above threshold |
Risk of bacteremia | 0.017 | 0.005 | PECARN | Boston |
Risk of death, delayed antibiotics | 0.10 | 0.03 | PECARN | Boston |
Strategy sensitivity | ||||
PECARN | 92% | 98% | Boston | PECARN |
Strategy specificity | ||||
Boston | 53% | 52% | PECARN | Boston |
PECARN | 52% | 57% | Boston | PECARN |
Rochester | 48% | 59% | Boston | Rochester |
Clinical suspicion | 37% | 81% | Boston | Clinical suspicion |